Applied Dna Sciences (NASDAQ:BNBX) Stock Price Down 5.8% – What’s Next?

Applied Dna Sciences Inc (NASDAQ:BNBX)’s stock price traded down 5.8% during mid-day trading on Monday . The stock traded as low as $0.4795 and last traded at $0.5551. 35,758,480 shares changed hands during trading, an increase of 5,769% from the average session volume of 609,245 shares. The stock had previously closed at $0.5890.

Analysts Set New Price Targets

Separately, Weiss Ratings initiated coverage on Applied Dna Sciences in a research report on Monday, January 26th. They set a “sell (e+)” rating for the company. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Applied Dna Sciences presently has a consensus rating of “Sell”.

Applied Dna Sciences Stock Up 4.9%

The company has a 50-day moving average price of $0.70. The firm has a market capitalization of $2.95 million, a PE ratio of 0.00 and a beta of 0.72.

Applied Dna Sciences (NASDAQ:BNBX) last issued its earnings results on Friday, December 19th. The company reported $122.52 EPS for the quarter. The firm had revenue of $0.20 million during the quarter.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.